Logan Stone Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Logan Stone Capital’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$593K	Buy	41,330 +19,593	+90%	+$291K	0.16%	79
2025 Q4	$327K	Buy	+21,737	New	+$326K	0.08%	115
2024 Q3	–	Sell	-115,244	Closed	-$1.77M	–	133
2024 Q2	$1.77M	Buy	+115,244	New	+$1.75M	0.46%	61
2024 Q1	–	Sell	-279,830	Closed	-$4.1M	–	147
2023 Q4	$4.1M	Buy	+279,830	New	+$3.91M	0.83%	42
2023 Q1	–	Sell	-338,129	Closed	-$5.22M	–	166
2022 Q4	$5.22M	Buy	338,129 +84,373	+33%	+$1.31M	1.95%	7
2022 Q3	$3.79M	Buy	253,756 +75,999	+43%	+$1.26M	2.49%	9
2022 Q2	$2.92M	Buy	177,757 +96,680	+119%	+$1.66M	2.15%	8
2022 Q1	$1.63M	Buy	+81,077	New	+$1.68M	1.17%	21

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Logan Stone Capital's BMEZ Position: Q1 2026 in Review

Logan Stone Capital increased its BlackRock Health Sciences Trust II (BMEZ) stake by 90% in Q1 2026, buying an estimated $291K and bringing the position to 41,330 shares worth $593K. The position accounts for 0.16% of the portfolio, ranked #79.

Logan Stone Capital first reported a position in BMEZ in Q1 2022 and has held it in 8 quarters since. The position peaked at $5.22M in Q4 2022. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

Logan Stone Capital held 41,330 shares of BlackRock Health Sciences Trust II worth $593K as of Q1 2026.
Logan Stone Capital bought 19,593 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $291K.
BlackRock Health Sciences Trust II made up 0.16% of Logan Stone Capital's portfolio in Q1 2026, its #79 holding.
Logan Stone Capital first reported a position in BlackRock Health Sciences Trust II in Q1 2022 and has held it in 8 quarters since.
Logan Stone Capital's BlackRock Health Sciences Trust II position peaked at $5.22M in Q4 2022.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Logan Stone Capital's 13F filing for Q1 2026, filed 15 May 2026.